ANTITUMOR ACTIVITY OF BEVACIZUMAB IN COMBINATION WITH METRONOMIC CHEMOTHERAPY (MPEBEV REGIMEN) IN METASTATIC NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Correale, Pierpaolo
Botta, Cirino
Martellucci, Ignazio
Licchetta, Antonella
Migali, Cristina
Bestoso, Elena
Apollinari, Serena
Guglielmo, Annamaria
Rossi, Marcello
Addeo, Raffaele [2 ]
Luzzi, Luca [1 ]
Gotti, Giuseppe
Tagliaferri, Pierosandro [3 ]
机构：
[1] S Maria Alle Scotte Hosp, Thorac Surg Unit, Siena, Italy
[2] S Giovanni Di Dio Hosp, San Giovanni Rotondo, Italy
[3] Magna Graecia, Catanzaro, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; bevacizumab; metronomic-chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1237 / S1237
页数：1
相关论文
共 50 条
  • [41] Retrospective analysis of survival and safety of bevacizumab biosimilar and original drug combination chemotherapy in non-small cell lung cancer
    Zhang, Xinyi
    Chu, Xiaofei
    Wang, Jun
    Gu, Wenjing
    Fu, Xiaoyan
    Zhang, Jing
    Wang, Congying
    Han, Qinghui
    Zhou, Jing
    Zhang, Yongjing
    Liu, Xiaoyan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer
    Niyongere, Sandrine
    Saltos, Andreas
    Gray, Jhanelle E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S433 - S450
  • [43] Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer
    Fournel, P.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S94 - S100
  • [44] Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naive Metastatic Non-small Cell Lung Cancer
    Liu, S-Y.
    Zhou, Q.
    Yan, H-H.
    Gan, B.
    Yang, M-Y.
    Deng, J-Y.
    Tu, H-Y.
    Zhang, X-C.
    Su, J.
    Yang, J-J.
    Wu, Y-L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S381 - S382
  • [45] Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
    W. Schuette
    I. Bork
    B. Wollschläger
    S. Schädlich
    Clinical Drug Investigation, 2001, 21 : 161 - 168
  • [46] Nimotuzumab in Combination With Chemotherapy in the Patients With Advanced Non-small Cell Lung Cancer
    Wang, H.
    Li, L.
    Zhang, H.
    Qian, Z.
    Qiu, L.
    Li, W.
    Liu, X.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S630 - S631
  • [47] Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer
    Tumolo, S
    Toffoli, G
    Saracchini, S
    Lo Re, G
    Bruschi, G
    Boccieri, MG
    LUNG CANCER, 2001, 34 : S37 - S46
  • [48] Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer
    Schuette, W
    Bork, I
    Wollschläger, B
    Schädlich, S
    CLINICAL DRUG INVESTIGATION, 2001, 21 (03) : 161 - 168
  • [49] SYNERGISTIC ANTITUMOR ACTIVITY OF BEVACIZUMAB AND ERLOTINIB IN EGFR-MUTATED NON-SMALL CELL LUNG CANCER XENOGRAFT MODELS
    Moriya, Yoichiro
    Yamamoto, Kaname
    Yanagisawa, Mieko
    Yorozu, Keigo
    Kurasawa, Mitsue
    Furugaki, Koh
    Iwai, Toshiki
    Ishikura, Nobuyuki
    Harada, Naoki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S768 - S768
  • [50] Safety, Tolerability and Clinical Activity of Selinexor in Combination with Pembrolizumab in Metastatic Non-small Cell Lung Cancer
    Altan, M.
    Tu, J.
    Milton, D. R.
    Yilmaz, B.
    Fossella, F. V.
    Mott, F. E.
    Blumenschein, G. R.
    Stephen, B. A.
    Karp, D. D.
    Naing, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S367 - S368
12345